insights_auto
Why is COR up २.९९%?
Dive Deeperchevron_right
COR:NYSE
Cencora Inc
US$ ३५९.०३
arrow_upward
+२.९९%(+१०.४२) 1D
US$ ३५९.०३
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर १३, १६:००:०४ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for COR...
Open
US$ ३५१.१२
High
US$ ३५९.३९
Low
US$ ३५०.११
Mkt. cap
१५.८७ अरब
Avg. vol.
१३.०५ लाख
Volume
१३.९३ लाख
52-wk high
US$ ३७७.५४
52-wk low
US$ २४४.८२
Beta
०.५८
Shares outstanding
१९.०८ करोड
No. of employees
४९ हजार
Open
US$ ३५१.१२
High
US$ ३५९.३९
Low
US$ ३५०.११
Mkt. cap
१५.८७ अरब
Avg. vol.
१३.०५ लाख
Volume
१३.९३ लाख
52-wk high
US$ ३७७.५४
52-wk low
US$ २४४.८२
Beta
०.५८
Shares outstanding
१९.०८ करोड
No. of employees
४९ हजार
News stories
From web sources and news partners
News Corp
·
१ दिन पहिले
Cencora Inc. stock outperforms competitors on strong trading day
Investing.com
·
१ दिन पहिले
US FTC sues to block Cencora’s $3.5 billion sale of veterinary unit to Covetrus By Reuters
Profile
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area. Wikipedia
About Cencora Inc